FDA Warns of Rare Vision Risk Linked to GLP-1 Drugs
FDA analyses found a small increase in NAION cases among people taking GLP-1 drugs, which are used by 30 million Americans.
Makkler Newsroom · Nov 14, 12:08 AM · 1 min read
Fidia S.p.A. FDA
MILProducer ManufacturingItaly
€0.01620.00 (0.00%)
Market closed· · EUR · Data may be delayed
- Day's range
- 0.020.02
- 52-week range
- 0.000.22
Financial health
– / 5
Analyst opinion
Not enough data
Prices may be delayed and are for informational purposes only - not investment advice.